CQ Science

📍 Denver, United States🗓 Founded 2018👥 2 employees💰 Last funded Jan 2018
Research Services🌐 cq-science.com
Website LinkedIn
CQ Science began as a pre-clinical stage organization exploring multiple compounds and molecules to address inflammation in skin. The genesis of the company came from many clinicians' desire to study cannabinoids for conditions including, but not limited to: atopic dermatitis, epidermis bullosa, hydradenitis suppurativa, and intractable itch. Anecdotal reports of topical creams helping these complicated conditions was encouraging. However, early pre-clinical data was mixed, not warranting raising additional funds to move into the clinical stage. Pivot: CQ Science then became the parent company of CQuell, a Dermatologist founded sensitive skin brand. Many of the products became consumer favorites, particularly the Moisture Locking Balm. However, there was speculation that the base and inactive ingredients were providing as much, if not more, of the efficacy. With cannabinoids not living up to their potential as an ingredient (delivered topically); the decision to cease operations was made in late 2022.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2018
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in CQ Science?
CQ Science has 1 investors on record on gritt.io, including 1 early-stage backers.
When did CQ Science last raise funding?
The most recent investment in CQ Science recorded on gritt.io was in January 2018.
When was CQ Science founded?
CQ Science was founded in 2018.
What industry is CQ Science in?
CQ Science operates in Research Services. Find similar Research Services investors on gritt.io.
Where is CQ Science based?
CQ Science is headquartered in Denver, United States.